| Literature DB >> 15853612 |
Abstract
Botulinum toxin type A (Botox) is increasingly used in the management of migraine and tension-type headaches. The results from small placebo-controlled trials and extensive open-label experience has suggested a significant role for this neurotoxin in the management of refractory headache. Several large placebo-controlled trials of episodic and chronic migraine are currently underway.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15853612 DOI: 10.1586/14737175.4.1.27
Source DB: PubMed Journal: Expert Rev Neurother ISSN: 1473-7175 Impact factor: 4.618